Month: April 2024

MEXICO CITY, April 22, 2024 (GLOBE NEWSWIRE) — Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central, and South America, today announces its financial results for the first quarter 20241. First Quarter 2024 Highlights(All figures are reported in U.S. dollars and compared to 1Q 2023 unless otherwise noted)Net income of $33 million. Earnings per ADS of $0.29 cents. Total operating revenues of $768 million, a 5.1% increase. Total revenue per available seat mile (TRASM) increased 21% to $9.34 cents. Available seat miles (ASMs) decreased by 13% to 8.2 billion. Total operating expenses of $664 million, representing 86% of total operating revenue. Total operating expenses per available seat mile (CASM)...

GUADALAJARA, Mexico, April 22, 2024 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reports its consolidated results for the first quarter ended March 31, 2024 (1Q24). Figures are unaudited and prepared following International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). Summary of Results 1Q24 vs. 1Q23The sum of aeronautical and non-aeronautical services revenues increased by Ps. 156.9 million, or 2.4%. Total revenues increased by Ps. 155.0 million, or 1.9%. Cost of services increased by Ps. 105.3 million, or 10.9%. Income from operations decreased by Ps. 92.1 million, or 2.3%. EBITDA decreased by Ps. 47.2 million, or 1.0%, a decrease from Ps. 4,696.1 million in 1Q23 to Ps. 4,648.9 million in 1Q24....

SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided an update on its corporate activities and product pipeline. “2023 included significant accomplishments throughout our business within both our Cloudbreak® drug-Fc conjugate (DFC) and our REZZAYO® (rezafungin) programs,” said Jeffrey Stein, Ph.D., president and chief executive officer of Cidara. “With respect to our DFC platform, we continue to generate and present compelling data from our oncology programs as well as...

Fourth quarter revenue grew 39% year-over-year to $116 million Posts record full year revenue of $421 million, up 36% year-over-year, and ARR growth accelerates to 43% year-over-year BETHESDA, Md., April 22, 2024 (GLOBE NEWSWIRE) — iLearningEngines, Inc. (NASDAQ: AILE) (“iLearningEngines”, “ILE”, or “the Company”), a leader in AI-powered learning automation and information intelligence for corporate and educational use, today announced financial results for the fourth quarter and fiscal year ended December 31, 2023. “The fourth quarter capped off a strong 2023,” said Harish Chidambaran, Chief Executive Officer of iLearningEngines. “During 2023, we expanded our core markets, grew end customers and licensed users, achieved 36% revenue growth year-over-year, and reached $447 million of annual recurring revenue . We are pleased...